Activated T lymphocytes are generated during an immune response. T h e induction of T lymphocyte proliferation is one way in which cell numbers can be controlled. However, once generated, the increased numbers of cells must be removed in order to re-establish cellular homoeostasis within the immune system. In this paper we describe how the numbers of activated T cells can be regulated by two distinct mechanisms, namely apoptosis and replicative senescence. In addition, we suggest that the regulation of cell clearance, as opposed to cell persistence, after an immune response is intimately involved in the generation of immune memory.
Introduction
Primary infection with Epstein-Barr virus (EBV), resulting in acute infectious mononucleosis, is characterized by large expansions of CD8' effector T lymphocytes [1, 2] . Continuous expansion of these populations is prevented by apoptosis at the end of the response, which returns the CD8' T cell pool size to pre-infection levels [3, 4] . However, virus-specific cells are known to persist in the body [5] . These cells comprise the memory pool, capable of reacting upon subsequent encounter with the virus. For memory to be generated, virusspecific cells have to escape both apoptosis and replicative senescence, which limits the capacity of cells to expand continuously. Activated T cells can be rescued from apoptosis by the family of interleukin-2 receptor (IL-2R)-common-y-chain cytokines and type I interferon (IFN) [6-111. Replicative senescence is delayed by a dramatic increase in the enzyme telomerase, enabling the preservation of long telomeres after such large expansion Key words: Epstein-Bar virus, type I interferon, intedeukin-2-related cytokines. telomerase, telomere.
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[l]. In this paper we will discuss these mechanisms which enable the generation and persistence of memory cells following viral infection.
Apoptosis during acute viral infections
Viral infections, such as with EBV, result in T lymphocytosis comprising mainly CD8+ T lymphocytes. In such situations, high numbers of effector CD8' T lymphocytes are generated which actively secrete inflammatory cytokines and exert potent cytotoxic activity. A tight control of the immune response is therefore crucial, so that organ damage can be avoided. Furthermore, at the end of the immune response, lymphocyte numbers must return to normal levels so that a homoeostatic balance is achieved. Control of the immune response is partly achieved by apoptosis [3, 4] , a process of programmed cell death which is regulated by the expression of specific genes. Two mechanisms are thought to be involved in the removal of activated cells : (1) CD95-CD95-L interactions between highly activated CD8+ lymphocytes [12,13], and (2) cytokine deprivation [3, 11] . Activated CD8' lymphocytes increase their surface expression of CD95, and killing via CD95-L ligation is thought to take place by autocrine and paracrine mechanisms. Cytokine-deprivationinduced death is associated with decreased expression of the survival genes bcl-2 and bcl-xL and with a low Bcl-2/Bax ratio, rendering these cells susceptible to apoptosis [3] . Cell death by apoptosis is thought to play a major role in the control and resolution of acute viral infection. However, a population of specific lymphocytes must survive so that memory can be achieved. Epitope-specific CD8+ lymphocytes have been shown to persist for at least 3 years after EBV infection, suggesting that virus-specific lymphocytes are rescued and persist in the body [S] .
There are two major pathways thought to be involved in activated T cell rescue during acute viral infections, the first mediated by the family of IL-2R-common y-chain cytokines [6, 11] and the second mediated by type I I F N [7, 9] . In vitro studies have shown that CD8+ T lymphocytes from acute EBV infection can be prevented from undergoing apoptosis by the addition of cytokines belonging to the IL-2R-common-y-chain family (IL-2, IL-15, IL-7 and IL-4). Cytokines such as these promote the cell cycle and induce high levels of Bcl-2 and Bcl-xL expression, thus increasing the Bcl-2/Bax ratio [6] . In summary, during the acute stage of a viral infection, high numbers of highly activated CD8+ lymphocytes are generated. T h e propensity of these cells to undergo apoptosis prevents excessive immune stimulation and allows the down-regulation of lymphocyte numbers. However, some cells can be rescued by cytokines such as the IL-2R-common-y-chain cytokines and by type I I F N present in the tissue. Rescued lymphocytes can then migrate through the body and comprise a resting memory population.
A further pressure on the generation of memory is the replicative capacity of previously activated cells. Extensive proliferation reduces the replicative potential of cells, and for memory to persist these must also be prevented from entering replicative senescence, a process which will be discussed below.
Replicative senescence, telomeres and telomerase
In general terms, replicative senescence is a phenomenon which may take place in all normal eukaryotic cell types. It reflects the inability of normal somatic cells to divide indefinitely and is thought to be determined, at least in part, by telomere length (reviewed in [14] ).
Telomeres are structures of DNA and protein that lie at the ends of chromosomes. Telomeric DNA is made up of several kilobases of hexameric repeats of the sequence (TTAGGG),. Telomeres serve various functions in the cell, which include preventing end-to-end fusion, promoting chromosome stability and, as discussed below, preventing the degradation of important DNA sequences at chromosome ends [ 1 51. T h e relevance of telomere length to replicative senescence comes from the inability of cells to fully replicate the DNA terminus after each round of cell division. This is known as the 'end replication problem', which arises from the absolute requirement of DNA polymerase to use an RNA primer to initiate DNA synthesis. T h e removal of that primer at the end of replication leaves unreplicated ends at one end of the new DNA strands. T h e presence of telomeres at the ends of chromosomes prevents the degradation of important coding sequences. Instead, every time a cell divides, telomeric repeats are lost [16] . It appears that when telomeres become critically short, the cell stops dividing and becomes senescent [ 
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Telomere length has been referred to as a 'mitotic clock ', reflecting the replicative history of cells [ 181, However, compensatory mechanisms also exist that counteract telomere loss. Certain cell types under certain conditions can express telomerase, a reverse transcriptase able to add back telomeric sequences [19] . Human telomerase consists of two components, the catalytic subunit (hTERT) with reverse transcriptase activity and the RNA template (hTER), which is used by the catalytic subunit to synthesize new telomeric repeats [20, 21] . Telomerase activity is absent or very low in most somatic cell types. T h e exceptions are highly proliferative organs, in which telomerase seems to play an essential role. These include the epidermis, the intestine and the reproductive system [22] . T h e immune system is another instance where telomerase activity seems to be very important. Here, lymphocytes expressing telomerase at various stages during development, differentiation and activation seem to be able to alleviate the extensive proliferative pressure they are under [23-251. T h e presence of this enzyme in about 90% of tumours, and the observation that transfection of the enzyme into telomerase-negative cells extends their replicative capacity [26] , confirms its relevance to the maintenance of the replicative capacity of cells. In summary, the evidence so far points towards a role for telomere shortening in limiting the replicative capacity of cells. T h e modulation of telomerase activity by certain cell types such as lymphocytes allows for extended rounds of replication to take place. T h e particular situation of the control of replicative senescence in acute viral infections will now be addressed.
Telomere length and telomerase activity in CD8+ T lymphocytes
T h e immune system is under continuous pressure throughout life. Constant antigenic challenge means that large clonal expansions frequently take place, and the maintenance of memory requires the presence of cells with enough replicative capacity to mount an immune response. It is not surprising, therefore, that telomerase activity has been shown to be tightly regulated in lymphocytes [23-251, allowing for some preservation of telomere length, but avoiding unlimited replicative capacity, which could render cells more susceptible to malignant transformation.
Lymphocytes have been shown to have decreased telomere length with increasing age [ 181, and further examples of longer proliferative history and short telomeres can be found in the literature (reviewed in [27] ). Some examples include shorter telomeres in the subset of CD4+ and CD8' T lymphocytes associated with memory (CD45RO+) when compared with unprimed or virgin lymphocytes expressing the CD45RA isoform [28] . This is consistent with proliferation being associated with the transition from unprimed to antigen-experienced cells [29] . Telomere length within the CD45RA subset also decreases with age [28] , confirming observations that suggest a turnover in this population [30] . Bone marrow progenitors too have been shown to have decreased telomere length with increasing age, implying again that this population is undergoing proliferation [ 181. Further examples come from in vitro studies using T cell clones in which repeated re-stimulation leads to proliferation expressed in population doublings [15, 31] . Increasing population doublings are associated with a progressive decrease in telomere length and, at a terminal stage, replicative senescence.
As discussed above, during viral infections such as with EBV, large clonal expansions take place which could render antigen-experienced cells susceptible to replicative senescence, making them unable to mount a memory response upon later virus encounter.
CD28 is a co-stimulatory molecule, constitutively expressed on the T cell surface, that is transiently down-regulated after activation [32] .
CDVCD28-lymphocytes are known to accumulate during viral infections [33, 34] and with increasing age [35, 36] . Studies in normal and HIVinfected individuals have shown that CD8+CD28-T lymphocytes have shorter telomeres than the subset expressing CD28 [37, 38] . This observation not only confirms the association between telomere length and replicative history, but also implies that clonally expanded CD8+ T lymphocytes are closer to replicative senescence than the subset still expressing CD28. Further studies, however, have revealed quite surprising findings that point towards the existence of mechanisms that delay replicative senescence during acute viral infections [l] .
Measurement of telomere length and telomerase activity during the acute stage of EBV infection has revealed that CD8+ T cells have elongated telomeres, associated with high telomerase activity [l] . Furthermore, when particular Vp22 clonal expansions were analysed, these too were found to have elongated telomeres compared with the total CD8+ population. Telomere length returned to normal levels after resolution of the disease, and telomerase activity returned to normal low/undetectable levels [ 13. These findings suggest that, in order to avoid replicative senescence after clonal expansion, virus-specific lymphocytes increase their telomerase activity and elongate their telomeres during acute responses, and therefore may prevent rapid progression towards replicative senescence that would be irreconcilable with long-term memory.
Conclusion
In summary, activated CD8+ lymphocytes can be rescued from apoptosis by IL-2R-common-ychain cytokines and by type I IFN, thus allowing for the generation of a memory pool. However, if memory is to persist, these cells also need to escape or delay replicative senescence. Mechanisms which increase telomerase activity during clonal expansion enable preservation of telomere length and the maintenance of replicative potential in the memory pool.
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